<DOC>
	<DOCNO>NCT01491191</DOCNO>
	<brief_summary>Postsurgical pain become chronic last two month surgery . A neurogenic neuropathic pathogenesis hypothesize event reach high rate urologic gynecologic surgery . Palmitoylethanolamide ( PEA ) bind mast cell regulate pro-inflammatory factor release , without adverse event . The investigator assume perioperative administration PEA reduce chronic postsurgical pain incidence patient undergo urologic gynecologic elective surgery .</brief_summary>
	<brief_title>Palmitoylethanolamide Post-operative Pain Prevention</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Palmidrol</mesh_term>
	<criteria>patient undergo elective gynecological urological surgical procedure age &lt; 18 pregnancy nursing preexist chronic pain severe hepatic renal failure postoperative progression local cancer disease postoperative infection inflammation surgical wound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>surgical pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>prevention</keyword>
	<keyword>palmitoylethanolamide</keyword>
</DOC>